ANDREW CUSHENBERY: Open Payments
NPI 1467958967 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 22 payments from 7 companies in 2025. Trend: 2023 $174 · 2024 $658 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $209 |
| Novo Nordisk Inc | 12 | $137 |
| Boston Scientific Corporation | 2 | $68 |
| ABBVIE INC. | 2 | $54 |
| Amgen Inc. | 2 | $48 |
| Dexcom, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $15 |
Products named: BREZTRI, Ozempic, QULIPTA, REPATHA, Innova Vascular, ELUVIA, Dexcom G6 Transmitter, Wegovy.
Industry payments across FL — which companies pay providers there.
